Breaking News Instant updates and real-time market news.

FEYE

FireEye

$10.73

-0.07 (-0.65%)

, HCN

Welltower

$67.62

0.34 (0.51%)

10:27
03/20/17
03/20
10:27
03/20/17
10:27

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. BofA Merrill Lynch analyst Tal Liani upgraded FireEye (FEYE) to Buy saying the combination of low valuation and expectations, many new solutions, and recent sales leadership changes creates significant upside potential over the next two years. The analyst believes investors under-appreciate FireEye's quality of management, recovery strategy, and the quality of its technology and solutions. 2. Morgan Stanley upgraded Welltower (HCN) to Overweight from Equal Weight and raised its price target to $73 from $65, with analyst Vikram Malhotra calling the stock his preferred play on senior housing given its premium market position and a relatively younger portfolio. 3. Tiffany (TIF) upgraded to Outperform from Market Perform by William Blair analyst Dylan Carden, citing the recent stabilization of comps sales as well as upcoming easier comparisons. 4. Illumina (ILMN) upgraded to Outperform from Market Perform at Leerink by analyst Puneet Souda , who said survey data across high-productivity labs suggest earlier than expected NovaSeq upgrades in 2017 and 2018. 5. Wedbush analyst Nick Setyan upgraded Shake Shack (SHAK) to Neutral from Underperform, saying valuation is now more in line with long-term opportunities. Setyan believes same-store-sales growth headwinds and softer new unit volumes in 2017 are now well understood and raised Shake Shack's price target to $33 from $30. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

FEYE

FireEye

$10.73

-0.07 (-0.65%)

HCN

Welltower

$67.62

0.34 (0.51%)

TIF

Tiffany

$94.55

2.13 (2.30%)

ILMN

Illumina

$160.42

0.96 (0.60%)

SHAK

Shake Shack

$32.24

-0.21 (-0.65%)

  • 01

    Apr

  • 20

    Jun

FEYE FireEye
$10.73

-0.07 (-0.65%)

02/03/17
EVER
02/03/17
NO CHANGE
Target $14
EVER
Buy
FireEye price target lowered to $14 from $26 at Evercore ISI
Evercore ISI analyst Ken Talanian lowered FireEye's price target to $14 following the Q4 revenue miss and guidance, and the CFO departure. The analyst said even though product declines have dragged down overall billing, it continues to generate recurring billings, suggesting a reasonable dollar based renewal rate. With shares down approximately 18% in the aftermarket, Talanian said sum-of-the-parts valuation suggests upside, even if it never sells a new deal again and captures only the cash flow from the recurring business into perpetuity. The analyst has a Buy rating on FireEye.
02/03/17
FBNS
02/03/17
DOWNGRADE
FBNS
Sector Perform
FireEye downgraded to Sector Perform from Outperform at FBN Securities
02/06/17
IMPC
02/06/17
NO CHANGE
Target $12
IMPC
In-Line
Imperial says FireEye investors could remain sidelined until billings grow again
Imperial Capital analyst Michael Kim lowered his price target on FireEye to $12 from $15 after the company reported Q4 revenue and billings that missed expectations and said he thinks investors could stay on the sidelines until billings growth returns. He keeps an In-Line rating on FireEye shares.
03/20/17
BOFA
03/20/17
UPGRADE
Target $18
BOFA
Buy
FireEye upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Tal Liani upgraded FireEye to Buy and raised its price target to $18 from $13.50 saying the combination of low valuation and expectations, many new solutions, and recent sales leadership changes creates significant upside potential over the next two years. The analyst believes investors underappreciate FireEye's quality of management, recovery strategy, and the quality of its technology and solutions that will drive 2H 2017 growth. Liani said FireEye has some of the most advanced threat intelligence dealing with network threats, endpoint protection, and analytics and threat management tools.
HCN Welltower
$67.62

0.34 (0.51%)

01/20/17
RHCO
01/20/17
DOWNGRADE
RHCO
Hold
Welltower downgraded on valuation, growth outlook at SunTrust
As noted earlier, SunTrust downgraded Welltower to Hold from Buy. Analyst Eric Fleming downgraded the stock based on valuation and his belief that the company's growth will moderate in the near-term, generating a performance that will be in-line with its sector. Target to $72 from $80.
03/20/17
03/20/17
UPGRADE
Target $73

Overweight
Welltower upgraded to Overweight from Equal Weight at Morgan Stanley
As previously reported, Morgan Stanley upgraded Welltower to Overweight from Equal Weight and raised its price target to $73 from $65. Analyst Vikram Malhotra said Welltower is his preferred play on senior housing given its premium market position, a relatively younger portfolio, and faces relatively less new supply.
03/20/17
MSCO
03/20/17
UPGRADE
MSCO
Overweight
Welltower upgraded to Overweight from Equal Weight at Morgan Stanley
02/23/17
MUFG
02/23/17
NO CHANGE
MUFG
Overweight
Welltower price target raised to $75 from $72 at MUFG
MUFG analyst Karin Ford reaffirmed her Overweight rating and raised her price target on Welltower shares to $75 from $72 following the company's Q4 earnings report, which reported FFO per share that beat MUFG estimates by a penny.
TIF Tiffany
$94.55

2.13 (2.30%)

03/16/17
OPCO
03/16/17
NO CHANGE
Target $105
OPCO
Outperform
Tiffany price target raised to $105 from $87 at Oppenheimer
Oppenheimer analyst Brian Nagel raised his price target for Tiffany to $105 from $87 as he is "increasingly optimistic" that fresh eyes within the company's senior ranks might bring an improved executional acumen and operating disciplines to the chain. The analyst reiterates an Outperform rating on the shares.
03/15/17
JEFF
03/15/17
NO CHANGE
Target $102
JEFF
Buy
Jefferies sees catalysts for Tiffany, reiterates $102 price target
Jefferies analyst Randal Konik reiterates a Buy rating on shares of Tiffany with a $102 price target. The company has a strong positioning in a growing market, Konik tells investors in a research note. He believes improvements in fashion jewelry, easing tourism headwinds and more innovative marketing efforts present catalyst for the stock.
03/17/17
JEFF
03/17/17
NO CHANGE
Target $110
JEFF
Buy
Tiffany price target raised to $110 after Q4 results at Jefferies
Jefferies analyst Randal Konik raised his price target for Tiffany shares to $110 from $102 following the company's Q4 results. With sales accelerating, margins strengthening and product newness accelerating soon, the stock should move higher, Konik tells investors in a research note. He reiterates a Buy rating on Tiffany.
03/20/17
WBLR
03/20/17
UPGRADE
WBLR
Outperform
Tiffany upgraded to Outperform from Market Perform at William Blair
William Blair analyst Dylan Carden upgraded Tiffany to Outperform citing the recent stabilization of comps sales as well as upcoming easier comparisons.
ILMN Illumina
$160.42

0.96 (0.60%)

02/27/17
EVER
02/27/17
UPGRADE
EVER
Buy
Illumina upgraded to Buy from Hold at Evercore ISI
Evercore ISI analyst Ross Muken to Buy with a $190 price target following customer checks that lead him to above consensus revenue forecasts. Muken believes Illumina will sell 750-1,300 NovaSeq boxes over the next several years as sequencing enters a new era of utility. He sees an expansion in the sequencing landscape given Nova's application flexibility and believes it addresses capacity utilization challenges. Muken's forecast is now above consensus and expects performance to accelerate into 2H revenue beats and a solid pathway into 2018.
02/07/17
COWN
02/07/17
NO CHANGE
Target $17
COWN
Outperform
GenMark concern surrounding NeoPrep discontinuation overblown, says Cowen
Cowen analyst Doug Schenkel noted GenMark (GNMK) shares have declined 10% year-to-date, which he attributes to concerns surrounding Illumina's (ILMN) decision to discontinue NeoPrep. The analyst believes these concerns are overblown as the company has entered into an amended supply agreement, which was confirmed in their 10-Q. Schenkel maintained his Outperform rating and $17 price target on GenMark shares.
02/27/17
02/27/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Steven Madden (SHOO) upgraded to Buy from Neutral at B. Riley by analyst Jeff Van Sinderen, who said last week's footwear show and latest channel checks underscore the company's potential for growth. 2. Illumina (ILMN) upgraded to Buy from Hold at Evercore ISI by analyst Ross Muken following customer checks that lead him to above consensus revenue forecasts. Muken believes Illumina will sell 750-1,300 NovaSeq boxes over the next several years as sequencing enters a new era of utility. 3. Carnival (CCL) upgraded Buy from Hold by Argus analyst John Staszak, who now believes that "continued " improvement in demand for cruises will improve the company's earnings and margins. 4. Cempra (CEMP) upgraded to Buy at Roth Capital by analyst Michael Higgins after the company announced positive Phase 3 results in the first of two skin infection studies with Taksta, and ahead of bone data in 2017. The analyst also raised his price target on the shares to $8 from $2.50. 5. Unilever (UN) upgraded to Neutral from Underperform at BofA Merrill Lynch by analyst David Hayes, citing valuation and his belief that the strategic review could accelerate margin development targets over the next 4 years. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/20/17
LEER
03/20/17
UPGRADE
Target $195
LEER
Outperform
Illumina upgraded to Outperform from Market Perform at Leerink
Leerink analyst Puneet Souda upgraded Illumina to Outperform and raised his price target for the shares to $195 from $138. Survey data across high-productivity labs suggest earlier than expected NovaSeq upgrades in 2017 and 2018, Souda tells investors in a research note.
SHAK Shake Shack
$32.24

-0.21 (-0.65%)

03/08/17
GSCO
03/08/17
NO CHANGE
Target $34
GSCO
Sell
Shake Shack traffic challenges a growing risk, says Goldman
Goldman analyst Karen Holthouse said Shake Shake reported in-line Q4 earnings of 9c but believes investors are too dismissive regarding decelerating traffic trends. The analyst continues to view cannibalization as a growing risk to Shake Shack's traffic trends and said openings outside of New York have substantially less excitement. Holthouse also sees increased labor challenges from staffing growth and increased compensation rates ahead of market rates. The analyst rates Shake Shack a Sell and lowered its price target to $34 from $38.
03/17/17
RHCO
03/17/17
NO CHANGE
RHCO
Shake Shack new restaurant guidance conservative, says SunTrust
SunTrust analyst Jake Bartlett says that Shake Shack has opened five stores so far this quarter and plans to open a sixth next week, versus the firm's estimate of four new restaurants. The analyst believes that the company's guidance of 22-23 restaurant openings for 2017 is now conservative. He increased his estimates for the company and raised his price target to $50 from $49 while keeping a Buy rating.
03/20/17
WEDB
03/20/17
UPGRADE
Target $33
WEDB
Neutral
Shake Shack upgraded to Neutral from Underperform at Wedbush
Wedbush analyst Nick Setyan upgraded Shake Shack to Neutral from Underperform and removed it from the Best Ideas List saying valuation is now more in line with long-term opportunities. Setyan believes same-store-sales growth headwinds and softer new unit volumes in 2017 are now well understood and raised Shake Shack's price target to $33 from $30
03/02/17
RHCO
03/02/17
NO CHANGE
RHCO
Shake Shack SSS miss creates buying opportunity, says SunTrust
SunTrust analyst Jake Bartlett says that Shake Shak's lower than expected Q1 SSS increase has created a good buying opportunity. He says that the company's store growth guidance is "strong," while its comparisons ease starting in Q2. The analyst also expects SSS to be boosted by "menu pricing, the new Shack app and strong promotions." He keeps a $49 price target and a Buy rating on the shares.

TODAY'S FREE FLY STORIES

DGII

Digi International

$9.70

0.4 (4.30%)

10:43
05/23/17
05/23
10:43
05/23/17
10:43
Upgrade
Digi International rating change  »

Digi International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SXI

Standex

$88.80

-0.05 (-0.06%)

10:40
05/23/17
05/23
10:40
05/23/17
10:40
Conference/Events
Standex management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBPX

Continental Building

$24.15

0.05 (0.21%)

10:39
05/23/17
05/23
10:39
05/23/17
10:39
Conference/Events
Continental Building management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MXIM

Maxim Integrated

$46.69

-0.16 (-0.34%)

10:38
05/23/17
05/23
10:38
05/23/17
10:38
Hot Stocks
Maxim Integrated anticipates strong cash flow growth »

All strategies are geared…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

10:35
05/23/17
05/23
10:35
05/23/17
10:35
General news
The 11.4% April new home sales plunge »

The 11.4% April new home…

TARO

Taro Pharmaceutical

$108.86

-3.465 (-3.08%)

10:32
05/23/17
05/23
10:32
05/23/17
10:32
Downgrade
Taro Pharmaceutical rating change  »

Taro Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MXIM

Maxim Integrated

$46.69

-0.16 (-0.34%)

10:30
05/23/17
05/23
10:30
05/23/17
10:30
Hot Stocks
Maxim says has 'great' products for power management in industrial business »

The company sees factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

EWS

iShares MSCI Singapore Index

$23.77

-0.06 (-0.25%)

10:30
05/23/17
05/23
10:30
05/23/17
10:30
Options
Opening interest in iShares MSCI Singapore ETF options »

Opening interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLND

Talend

$31.85

-0.16 (-0.50%)

10:28
05/23/17
05/23
10:28
05/23/17
10:28
Conference/Events
Talend management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

  • 13

    Jun

WYN

Wyndham

$96.72

0.73 (0.76%)

10:28
05/23/17
05/23
10:28
05/23/17
10:28
Conference/Events
Wyndham management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

SOHU

Sohu.com

$49.22

3.09 (6.70%)

10:27
05/23/17
05/23
10:27
05/23/17
10:27
Downgrade
Sohu.com rating change  »

Sohu.com downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BHP

BHP Billiton

$36.45

-0.44 (-1.19%)

, BCS

Barclays

$11.10

-0.04 (-0.36%)

10:26
05/23/17
05/23
10:26
05/23/17
10:26
Periodicals
BHP hires Barclays to divest U.S. shale gas assets, Reuters reports »

BHP (BHP) has hired…

BHP

BHP Billiton

$36.45

-0.44 (-1.19%)

BCS

Barclays

$11.10

-0.04 (-0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

TWOU

2U

$42.99

1 (2.38%)

10:26
05/23/17
05/23
10:26
05/23/17
10:26
Conference/Events
2U management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

STL

Sterling Bancorp

$21.75

-0.1 (-0.46%)

10:25
05/23/17
05/23
10:25
05/23/17
10:25
Conference/Events
Sterling Bancorp management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

LULU

lululemon

$49.51

0.22 (0.45%)

10:25
05/23/17
05/23
10:25
05/23/17
10:25
Hot Stocks
lululemon falls following website outages »

Shares of lululemon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

SAP

SAP

$106.14

0.4 (0.38%)

10:24
05/23/17
05/23
10:24
05/23/17
10:24
Conference/Events
SAP management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 31

    May

MXIM

Maxim Integrated

$46.69

-0.16 (-0.34%)

10:24
05/23/17
05/23
10:24
05/23/17
10:24
Hot Stocks
Breaking Hot Stocks news story on Maxim Integrated »

Maxim Integrated sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

JNJ

Johnson & Johnson

$128.09

0.83 (0.65%)

10:23
05/23/17
05/23
10:23
05/23/17
10:23
Hot Stocks
Breaking Hot Stocks news story on Johnson & Johnson »

J&J CFO says creating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 06

    Jun

ONB

Old National Bancorp

$16.10

-0.05 (-0.31%)

10:22
05/23/17
05/23
10:22
05/23/17
10:22
Conference/Events
Old National Bancorp management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 25

    May

  • 18

    Sep

MXIM

Maxim Integrated

$46.69

-0.16 (-0.34%)

, NVDA

Nvidia

$138.90

2.9 (2.13%)

10:22
05/23/17
05/23
10:22
05/23/17
10:22
Hot Stocks
Maxim says partnership with Nvidia 'works well,' no conflicts »

Also working with Nvidia…

MXIM

Maxim Integrated

$46.69

-0.16 (-0.34%)

NVDA

Nvidia

$138.90

2.9 (2.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 01

    Jun

  • 09

    Jun

JNJ

Johnson & Johnson

$128.09

0.83 (0.65%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Hot Stocks
Johnson & Johnson says wants to generate value for shareholders in any M&A deals »

Says looking at strategic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 06

    Jun

OFC

Corporate Office Properties

$33.66

0.08 (0.24%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Conference/Events
Corporate Office Properties management to meet with Jefferies »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

ALXN

Alexion

$115.42

1.58 (1.39%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Downgrade
Alexion rating change  »

Alexion downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

CLDR

Cloudera

$21.32

0.41 (1.96%)

, EEX

Emerald Expositions Events

$21.93

-0.075 (-0.34%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

CLDR

Cloudera

$21.32

0.41 (1.96%)

EEX

Emerald Expositions Events

$21.93

-0.075 (-0.34%)

ZYME

Zymeworks

$13.00

-0.06 (-0.46%)

CVNA

Carvana

$11.20

0.1165 (1.05%)

JBHT

J.B. Hunt

$84.25

0.11 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 25

    May

  • 31

    May

  • 02

    Jun

  • 08

    Jun

AZO

AutoZone

$603.74

-55.75 (-8.45%)

, HP

Helmerich & Payne

$56.79

-3.09 (-5.16%)

10:21
05/23/17
05/23
10:21
05/23/17
10:21
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

AZO

AutoZone

$603.74

-55.75 (-8.45%)

HP

Helmerich & Payne

$56.79

-3.09 (-5.16%)

FRSH

Papa Murphy's

$5.04

0.03 (0.60%)

COLM

Columbia Sportswear

$53.17

0.51 (0.97%)

XLNX

Xilinx

$67.52

0.85 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 24

    May

  • 01

    Jun

  • 13

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.